Absence of early metabolic response assessed by 18F-FDG PET-CT after initiation of antifibrotic drugs in IPF patients.
B. Bondue (Brussels, Belgium), A. Castiaux (Brussels, Belgium), G. Van Simaeys (Brussels, Belgium), C. Mathey (Brussels, Belgium), F. Sherer (Gosselies, Belgium), D. Egrise (Brussels, Belgium), S. Lacroix (Brussels, Belgium), F. Huaux (Brussels, Belgium), G. Doumont (Gosselies, Belgium), S. Goldman (Brussels, Belgium)
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Bondue (Brussels, Belgium), A. Castiaux (Brussels, Belgium), G. Van Simaeys (Brussels, Belgium), C. Mathey (Brussels, Belgium), F. Sherer (Gosselies, Belgium), D. Egrise (Brussels, Belgium), S. Lacroix (Brussels, Belgium), F. Huaux (Brussels, Belgium), G. Doumont (Gosselies, Belgium), S. Goldman (Brussels, Belgium). Absence of early metabolic response assessed by 18F-FDG PET-CT after initiation of antifibrotic drugs in IPF patients.. 2918
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: